Navigation Links
Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
Date:5/15/2008

poster presentations, Poniard will host an investor event on Sunday, June 1, at 6:30 p.m. in Chicago. The event will feature presentations and discussion with expert oncologists, including lung cancer expert Chandra Belani, M.D., of the University of Pittsburgh Medical Center; prostate cancer expert E. David Crawford, M.D., of the University of Colorado Health Sciences Center in Denver; and platinum therapy developer, Lloyd Kelland, Ph.D., of Cancer Research Technology and University College London, in addition to members of Poniard's senior management. For more information or to rsvp to the event, please email rsvp@poniard.com.

About Picoplatin

Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. Poniard is evaluating intravenous picoplatin in an ongoing pivotal Phase 3 trial, known as SPEAR (Study of Picoplatin Efficacy After Relapse), in small cell lung cancer. This registration trial currently is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration and is evaluating overall survival as the primary endpoint. The Company is also evaluating intravenous picoplatin in an ongoing Phase 2 clinical trial for the treatment of HRPC, and an ongoing Phase 2 clinical trial in patients with patients with metastatic CRC. Oral picoplatin is being evaluated in a Phase 1 clinical trial in solid tumors. The oral formulation of picoplatin has the same active pharmaceutical ingredient as the intravenous formulation. Picoplatin has not been approved by any regulatory authority for use in humans.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biop
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
2. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
3. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
4. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
5. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
6. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
7. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
8. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
9. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
10. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
11. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... At today,s regular meeting of the board ... LZ ), the board declared a regular quarterly dividend ... to holders of record at the close of business ... Corporation ,, The Lubrizol Corporation (NYSE: ... produces and supplies technologies that improve the quality and ...
(Date:12/15/2009)... Dec. 15 NxStage Medical, Inc. (Nasdaq: ... dialysis products, today announced that a group of ... be embarking on a week-long, conventional (non-dialysis) Caribbean ... The cruise, dubbed the "2010 Freedom Cruise: We,re ... Fla. on January 3, 2010 and returns on ...
(Date:12/15/2009)... Dec. 15 Varian Medical Systems (NYSE: ... results for first quarter of fiscal year 2010 following ... 2010. The news release will be followed by ... p.m. PT. The news release and a link ... the company website at: www.varian.com/investor . To ...
Breaking Medicine Technology:Lubrizol Declares Dividend 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2Oxygen Biotherapeutics Inc Expands Board of Directors 14593 1Oxygen Biotherapeutics Inc Expands Board of Directors 14593 2Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference 5691 1Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference 5691 2Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference 5691 3AMD LASERS Announces Partnerships With Three Industry Leading Companies 5686 1
(Date:12/15/2009)... couples of reproductive age were evaluated, Italian study found ... of children born with cystic fibrosis decreases when screening ... increases, a new study finds. , CF neonatal screening ... for many years. Since the 1990s, the area has ... infants born with CF. , Two different CF carrier ...
(Date:12/15/2009)... The American Diabetes Association and the CDC have released some sobering ... the United States. Treadmill desks offer employers an effective means of ... ... AZ (Vocus) December 14, 2009 -- Rates of diabetes are climbing ... in obesity rates. Despite this rise the American Diabetes Association has ...
(Date:12/15/2009)... -- 4R Systems, Inc., a leading provider of ... retailers significantly increase profits by optimizing their inventory ... The Vitamin Shoppe has been utilizing the 4R ... DC inventory solutions have helped us drive significant ... the last two years," said Tony Truesdale, President ...
(Date:12/15/2009)... The new compact LifeSpan TR200 folding treadmill, ... ), was highly praised by treadmill review groups ... The compact TR200 folding treadmill received awards for Best ... $1000. ,, The compact LifeSpan TR200 treadmill is ... spaces. "This category buster is a very compact treadmill ...
(Date:12/15/2009)... A new study links chronic obstructive pulmonary disease, ... as sentinels to activate the body,s immune system. ... adds to growing awareness of the immune system,s role ... more than 12 million Americans with wheezing, shortness of ... is key if doctors are to find better ways ...
Breaking Medicine News(10 mins):Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3
... Over Current Therapies, MARKHAM, Ontario, Nov. 6 ... novel vitamin D analog, CTA018, at the 2008,Annual ... in Philadelphia.,In preclinical models, CTA018 has demonstrated advantages ... and paricalcitol,(Zemplar(R)), the latter currently being the most ...
... 6 Spectrum Control, Inc.,(Nasdaq: SPEC ), ... and systems, announced today that its Microwave Business ... microwave integrated assembly used,in military tactical communication terminals. ... orders and releases under the program,expected periodically throughout ...
... be Web cast live, LAVAL, QC, Nov. 6 ... today that on Tuesday, November 11, Mr. Gary,Schmid, President ... wholly owned subsidiary of BELLUS Health, will present a ... and,Renshaw 10th Annual Healthcare Conference to be held at ...
... November 6, 2008Children born to mothers with pregnancy-related diabetes ... to a research team directed by Professor Ginette Dionne ... discovery are published in the most recent issue of ... compared the vocabulary and grammar skills of 221 children ...
... DALLAS, Nov. 6 TrailBlazer Health,Enterprises, LLC, one ... announced today that Gil R. Glover has been ... company., Based in Dallas, Texas, TrailBlazer Health ... Medicare and other government,programs. In 2007, TrailBlazer processed ...
... with a Focus on Fun, FORT WORTH, Texas, ... cheerleading program for girls and boys between the,ages of ... Gym of Fort Worth SW. With an,emphasis on fun, ... aspects of cheerleading, including sideline,cheers and chants, stunts and ...
Other Medicine News:Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 2Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 3Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 4Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 5Health News:Spectrum Control Receives $1.2 Million Order for Microwave Integrated Assemblies 2Health News:BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference 2Health News:Pregnancy diabetes doubles the risk of language delay in children 2Health News:TrailBlazer Health Enterprises Names New President, Chief Operating Officer 2Health News:The Little Gym of Fort Worth SW Introduces Kids' Cheerleading Program 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: